These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2139945)
1. [Imipenem-cilastatin in infections]. Armengaud M Presse Med; 1990 Apr; 19(13):629-33. PubMed ID: 2139945 [TBL] [Abstract][Full Text] [Related]
2. [Study of imipenem-cilastatin at intensive care units]. Leroy J Presse Med; 1990 Apr; 19(13):613-5. PubMed ID: 2139941 [TBL] [Abstract][Full Text] [Related]
3. [An imipenem-cilastatin combination in the treatment of infection at general intensive care units]. Gouin F Presse Med; 1990 Apr; 19(13):620-4. PubMed ID: 2139943 [TBL] [Abstract][Full Text] [Related]
4. [Value of an imipenem-cilastatin combination in surgery and surgical care units]. Bouletreau P Presse Med; 1990 Apr; 19(13):616-9. PubMed ID: 2139942 [TBL] [Abstract][Full Text] [Related]
5. [An imipenem-cilastatin combination in the treatment of infection in hemato-oncology]. Espinouse D Presse Med; 1990 Apr; 19(13):625-8. PubMed ID: 2139944 [TBL] [Abstract][Full Text] [Related]
6. A multicenter, randomized controlled clinical study on biapenem and imipenem/cilastatin injection in the treatment of respiratory and urinary tract infections. Jia B; Lu P; Huang W; Li C; Huang A; Zhou X; Zhang W; Wu G; Zhang G Chemotherapy; 2010; 56(4):285-90. PubMed ID: 20714145 [TBL] [Abstract][Full Text] [Related]
7. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group. Colardyn F; Faulkner KL J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726 [TBL] [Abstract][Full Text] [Related]
8. Monotherapy in serious hospital-acquired infections: a clinical trial of ceftazidime versus imipenem/cilastatin. European Study Group. Norrby SR; Finch RG; Glauser M J Antimicrob Chemother; 1993 Jun; 31(6):927-37. PubMed ID: 8360130 [TBL] [Abstract][Full Text] [Related]
9. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections. Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495 [TBL] [Abstract][Full Text] [Related]
10. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections. Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684 [TBL] [Abstract][Full Text] [Related]
11. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group. Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of imipenem/cilastatin in the treatment of severe bacterial infections. D'Amato C; Armignacco O; Antonucci G; Bordi E; Bove G; De Carli G; De Mori P; Rosci MA; Visco G J Chemother; 1990 Apr; 2(2):100-7. PubMed ID: 2193998 [TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled clinical trial on meropenem versus imipenem/cilastatin for the treatment of bacterial infections. Hou F; Li J; Wu G; Zheng B; Chen Y; Gu J; Wang H; Huo L; Xue X; Jia C; Yin Y; Tian X; Ren S Chin Med J (Engl); 2002 Dec; 115(12):1849-54. PubMed ID: 12622937 [TBL] [Abstract][Full Text] [Related]
14. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections. Kreter B Clin Ther; 1992; 14(1):110-21. PubMed ID: 1576620 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. Chen Z; Wu J; Zhang Y; Wei J; Leng X; Bi J; Li R; Yan L; Quan Z; Chen X; Yu Y; Wu Z; Liu D; Ma X; Maroko R; Cooper A BMC Infect Dis; 2010 Jul; 10():217. PubMed ID: 20663130 [TBL] [Abstract][Full Text] [Related]
16. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections. de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872 [TBL] [Abstract][Full Text] [Related]
17. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Cox CE; Holloway WJ; Geckler RW Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic equivalence of generic imipenem/cilastatin for therapy of infections at Siriraj Hospital. Piyasirisilp S; Premprawat W; Thamlikitkul V J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S117-25. PubMed ID: 20364566 [TBL] [Abstract][Full Text] [Related]
19. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study]. Tonelli F Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225 [TBL] [Abstract][Full Text] [Related]
20. [Use of imipenem in the treatment of patients with surgical infection]. Iakovlev VP; Blatun LA; Khlebnikov EP; Samykina TD; Elagina LV Antibiot Khimioter; 1995 Apr; 40(4):40-4. PubMed ID: 7654100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]